心脏瓣膜置换术后血栓栓塞并发症的药物控制。初步报告。 - Suppr

Suppr

超能文献

Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.

作者信息

Sullivan J M, Harken D E, Gorlin R

出版信息

N Engl J Med. 1968 Sep 12;279(11):576-80. doi: 10.1056/NEJM196809122791104.

DOI:10.1056/NEJM196809122791104

PMID:5667468

Abstract

摘要

相似文献

Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.

N Engl J Med. 1968 Sep 12;279(11):576-80. doi: 10.1056/NEJM196809122791104.

Pharmacologic control of thromboembolic complications of cardiac-valve replacement.

N Engl J Med. 1971 Jun 24;284(25):1391-4. doi: 10.1056/NEJM197106242842501.

Use of Persantine in preventing thromboembolism following valve replacement.

Am Surg. 1972 Aug;38(8):432-5.

Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.

J Thorac Cardiovasc Surg. 1986 Jan;91(1):92-8.

Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.

Z Kardiol. 1986;75 Suppl 2:321-5.

Late incidence and determinants of stroke after aortic and mitral valve replacement.

Ann Thorac Surg. 2004 Jul;78(1):77-83; discussion 83-4. doi: 10.1016/j.athoracsur.2003.12.058.

[Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].

Arch Mal Coeur Vaiss. 1982 Jan;75(1):85-8.

Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.

J Thorac Cardiovasc Surg. 1981 Apr;81(4):632-5.

[Replacement of the mitral and aortic valves with bioprostheses. Long-term results].

G Ital Cardiol. 1985 Oct;15(10):974-82.

Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.

J Heart Valve Dis. 1999 Nov;8(6):665-73.

引用本文的文献

Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum.

Br J Pharmacol. 1981 Feb;72(2):299-303. doi: 10.1111/j.1476-5381.1981.tb09129.x.

Coagulation studies in rheumatic heart disease.

Br Heart J. 1980 Mar;43(3):301-5. doi: 10.1136/hrt.43.3.301.

Effect of RA233 on platelet function in vitro.

Br Med J. 1970 Apr 11;2(5701):83-6. doi: 10.1136/bmj.2.5701.83.

Oral anticoagulant therapy.

Can Med Assoc J. 1971 Nov 20;105(10):1015-6.

Anticoagulant and thrombolytic drugs. II. Clinical aspects.

Drugs. 1971;1(4):303-19. doi: 10.2165/00003495-197101040-00003.

Platelet function: a review. II. Abnormal function.

Can Med Assoc J. 1970 Jun 20;102(13):1379-83.

Controlled trial of dipyridamole in cerebral vascular disease.

Br Med J. 1969 Mar 8;1(5644):614-5. doi: 10.1136/bmj.1.5644.614.

Thrombo-embolic complications of the cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral.

Thorax. 1973 Jan;28(1):41-7. doi: 10.1136/thx.28.1.41.

Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism.

Thorax. 1974 Nov;29(6):639-42. doi: 10.1136/thx.29.6.639.

Inhibition of adrenergic cardiopathies by drugs. II. Anticoagulants.

Arch Kreislaufforsch. 1970 May-Jun;62(1):65-71. doi: 10.1007/BF02119797.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验